We describe the clinical and pathological characteristics of seven patients who were human T-lymphotropic virus type 1 (HTLV-1) carriers and had a pathological diagnosis of de novo diffuse large B-cell lymphoma. Interestingly, three of our cases showed positive expression of Epstein-Barr-virus, (EBV-) encoded RNA within the tumor cells indicating a possible interaction between these two viruses. Furthermore, our three EBV-positive cases presented with similar clinical characteristics such as early clinical stage and low-risk indices. To the best of our knowledge, this is the first case series describing the characteristics of HTLV-1-positive DLBCL patients. The potential relationship between HTLV-1 and EBV should be further explored.
CITATION STYLE
Beltran, B. E., Quiñones, P., Morales, D., Revilla, J. C., Alva, J. C., & Castillo, J. J. (2012). Diffuse Large B-Cell Lymphoma in Human T-Lymphotropic Virus Type 1 Carriers. Leukemia Research and Treatment, 2012, 1–4. https://doi.org/10.1155/2012/262363
Mendeley helps you to discover research relevant for your work.